If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 41 - 50 of 274
A Phase III Randomized Trial of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with Cisplatin Versus No HIPEC At the Time of Interval Cytoreductive Surgery Followed by Niraparib Maintenance in Patients with Newly Diagnosed Stage III and IV Ovarian
Objective
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal & FT
Protocol No
GOG-3068-HOTT-HIPEC
Categories
A Phase 3, Open-Label, Multicenter, Randomized Study of Tarlatamab in Combination with Durvalumab vs Durvalumab Alone in Subjects with Extensive-Stage Small-Cell Lung Cancer Following Platinum, Etoposide and Durvalumab (DeLLphi-305)
Objective
Study comparing tarlatamab and durvalumab versus durvalumab alone in first-line ES-SCLC
Protocol No
AMG-757-20200041-DELLPHI-305
Categories
A Phase II Study of Biomarker Driven Early Discontinuation of Anti-PD-1 Therapy in Patients with Advanced Melanoma (PET-Stop)
Objective
Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
Protocol No
ECOG-EA6192
Categories
A Phase 1b Open-Label Study to Evaluate the Safety and Anti-Cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-Cancer Agents in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Objective
Study of loncastuximab tesirine in R/R B-cell Non-Hodgkin lymphoma patients
Protocol No
ADCT-402-105-LOTIS-7
Categories
Concept Identification for MEG Aphasia
Objective
Concept Identification for MEG Aphasia
Protocol No
ANES-IIT-GROSS-CONCEPT-ID
Categories
A Phase 1b/2, Open-Label, Dose Finding, and Expansion Study of the Bcl-2 Inhibitor BGB-11417 in Patients with Myeloid Malignancies
Objective
A Phase 1b/2 Study of BGB-11417 in Patients with Myeloid Malignancies
Protocol No
BEIGENE-BGB-11417-103
Categories
Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
Objective
Clinical trial of atrial fibrillation patients comparing left atrial appendage occlusion therapy to non-vitamin K antagonist oral anticoagulants
Protocol No
CVC-ABBOTT-CATALYST
Categories
Impella-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
Objective
Impella-Supported PCI in Complex Coronary Artery Disease PROTECT IV
Protocol No
CVC-ABIOMED-PROTECT-IV
Categories
Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
Objective
AccuCinch Ventricular Restoration System in HFrEF
Protocol No
CVC-ANCORA-CORCINCH-HF
Categories
Deliver Insights in Hypertrophic Cardiomyopathy and Observational Outcomes in Real World: United States Prospective Registry Study
Objective
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Protocol No
CVC-BMS-DISCOVER-HCM
Categories